Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Villani, P' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 53 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Terreni, M; Villani, P
      New anti-Mycobacterium agents: recent advances in patent literature

      EXPERT OPINION ON THERAPEUTIC PATENTS
    2. Regazzi, MB; Seminari, E; Villani, P; Carriero, PL; Montagna, M; Marubbi, F; Maserati, R
      Nelfinavir suspension obtained from nelfinavir tablets has equivalent pharmacokinetic profile

      JOURNAL OF CHEMOTHERAPY
    3. Villani, P; Demet, D; Ambrosi, P; Brondino-Riquier, R; Bouvenot, G
      Diagnostic and therapeutic management of urinary tract infections in medical wards in a Marseille University Hospital

      PRESSE MEDICALE
    4. Bruno, R; Regazzi, MB; Ciappina, V; Villani, P; Sacchi, P; Montagna, M; Panebianco, R; Filice, G
      Comparison of the plasma pharmacokinetics of lamivudine during twice and once daily administration in patients with HIV

      CLINICAL PHARMACOKINETICS
    5. Villani, P; Feroggio, M; Gianelli, L; Bartoli, A; Montagna, M; Maserati, R; Regazzi, MB
      Antiretrovirals: Simultaneous determination of five protease inhibitors and three nonnucleoside transcriptase inhibitors in human plasma by a rapid high-performance liquid chromatography-mass spectrometry assay

      THERAPEUTIC DRUG MONITORING
    6. Villani, P; Viale, P; Signorini, L; Cadeo, B; Marchetti, F; Villani, A; Fiocchi, C; Regazzi, MB; Carosi, G
      Pharmacokinetic evaluation of oral levofloxacin in human immunodeficiency virus-infected subjects receiving concomitant antiretroviral therapy

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    7. Seminar, E; Maggiolo, F; Villani, P; Suter, F; Pan, A; Regazzi, MB; Paolucci, S; Baldanti, F; Tinelli, C; Maserati, R
      Efavirenz, nelfiniavir, and stavudine rescue combination therapy in HIV-1-Positive patients heavily pretreated with nucleoside analogues and proteaseinhibitors (vol 22, pg 453, 1999)

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    8. Villani, P; Altavista, PL; Castaldi, L; Leter, G; Cordelli, E
      Analysis of DNA oxidative damage related to cell proliferation

      MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS
    9. Bouvenot, G; Villani, P
      Equivalence trials in rheumatology

      JOINT BONE SPINE
    10. Ambjorn, J; Carfora, M; Marzuoli, A; Villani, P
      Recent analytical results in 4D-dynamical triangulations

      NUCLEAR PHYSICS B-PROCEEDINGS SUPPLEMENTS
    11. Ambrosi, P; Calise, G; Villani, P; Luccioni, R; Bouvenot, G
      Prescription of low-molecular-weight heparin for venous thromboembolism prophylaxis in medical patients

      PRESSE MEDICALE
    12. Villani, P
      Classical and medieval literature criticism, Vol 26, Excerpts from criticism of the works of world authors from classical antiquity through the Fourteenth Century, from the first appraisals to current evaluations

      ASIAN FOLKLORE STUDIES
    13. Regazzi, MB; Villani, P; Maserati, R; Seminari, E; Pan, A; LoCaputo, F; Gambarana, E; Fiocchi, C
      Clinical pharmacokinetics of nelfinavir combined with efavirenz and stavudine during rescue treatment of heavily pretreated HIV-infected patients

      Journal of antimicrobial chemotherapy
    14. Maserati, R; Villani, P; Barasolo, G; Mongiovetti, M; Regazzi, MB
      Influenza immunization and indinavir pharmacokinetics

      SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES
    15. Villani, P
      Pierre Francois Lacheze and the Italian patriots - A French diplomat in Genoa in 1792

      RASSEGNA STORICA DEL RISORGIMENTO
    16. Seminari, E; Maggiolo, F; Villani, P; Suter, F; Pan, A; Regazzi, MB; Tinelli, C; Maserati, R
      Efavirenz, nelfinavir, and stavudine rescue combination therapy in HIV-1-positive patients heavily pretreated with nucleoside analogues and protease inhibitors

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    17. Daffaud, F; Orsiere, T; Villani, P; Volot, F; Favre, R; Botta, A
      Micronucleated lymphocyte rates from head-and-neck cancer patients

      MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS
    18. Villani, P; Mugnier, B; Bouvenot, G
      Muscle cramps: reevaluation of the efficacy of quinine salts

      PRESSE MEDICALE
    19. Villani, P; Regazzi, MB; Castelli, F; Viale, P; Torti, C; Seminari, E; Maserati, R
      Pharmacokinetics of efavirenz (EFV) alone and in combination therapy with nelfinavir (NFV) in HIV-1 infected patients

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    20. Regazzi, MB; Villani, P; Maserati, R; Cocchi, L; Giacchino, R; Burroni, D; Rettani, M
      Pharmacokinetic variability and strategy for therapeutic drug monitoring of saquinavir (SQV) in HIV-I infected individuals

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    21. Maserati, R; Villani, P; Seminari, E; Pan, A; Lo Caputo, S; Regazzi, MB
      High plasma levels of nelfinavir and efavirenz in two HIV-positive patients with hepatic disease

      AIDS
    22. Villani, P; Pregnolato, M; Banfo, S; Rettani, M; Burroni, D; Seminari, E; Maserati, R; Regazzi, MB
      High-performance liquid chromatography method for analyzing the antiretroviral agent efavirenz in human plasma

      THERAPEUTIC DRUG MONITORING
    23. Veneziano, D; Villani, P
      Best linear unbiased design hyetograph

      WATER RESOURCES RESEARCH
    24. Cordelli, E; Altavista, P; Leter, G; Castaldi, L; Villani, P
      Analysis of oxidative damage in cells in different phases of the cell cycle

      NEOPLASMA
    25. VILLANI P; BONDINORIQUIER R; BOUVENOT G
      THE FRAGILE NATURE OF SCIENTIFICALLY ACQU IRED DATA - THE EXAMPLE OF FLUORIDE SALTS FOR OSTEOPOROSIS

      La Presse medicale
    26. VILLANI P; BOUVENOT G
      ASSESSMENT OF THE PLACEBO-EFFECT OF SYMPT OMATIC SLOW-ACTING DRUGS GIVEN FOR OSTEOARTHRITIS

      La Presse medicale
    27. Villani, P
      World mythology: An annotated guide to collections and anthologies

      ASIAN FOLKLORE STUDIES
    28. VILLANI P; ANDREOLI C; CREBELLI R; PACCHIEROTTI F; ZIJNO A; CARERE A
      ANALYSIS OF MICRONUCLEI AND DNA SINGLE-STRAND BREAKS IN MOUSE SPLENOCYTES AND PERIPHERAL LYMPHOCYTES AFTER ORAL-ADMINISTRATION OF TETRAMETHYLTHIURAM DISULFIDE (THIRAM)

      Food and chemical toxicology
    29. RANALDI R; BASSANI B; VILLANI P; LOMBARDI CC; TANZARELLA C; PACCHIEROTTI F
      MEASUREMENT AND CHARACTERIZATION OF MICRONUCLEI IN CULTURED PRIMARY LUNG-CELLS OF MICE FOLLOWING INHALATION EXPOSURE TO BENZENE

      Mutagenesis
    30. Dalla Via, J; Villani, P; Gasteiger, E; Niederstatter, H
      Oxygen consumption in sea bass fingerling Dicentrarchus labrax exposed to acute salinity and temperature changes: metabolic basis for maximum stocking density estimations

      AQUACULTURE
    31. Villani, P; Orsiere, T; Duffaud, F; Digue, L; Bouvenot, G; Botta, A
      Genotoxic and clastogenic effects of doxorubicin

      THERAPIE
    32. Villani, P
      Revolution and diplomacy: Reinhard's first mission in Italy (1793)

      STUDI STORICI
    33. TINCANI A; FADEN D; MERONI PL; BRUCATO A; FRANCASCHINI F; SPATOLA L; LOIACONO A; PANZERI P; MUSCARA M; VILLANI P; CIMAZ R; SANTANTONIO A; EKPO GJ; TANZI P; TARANTINI M; FRASSI M; CATELLI L; VALSECCHI L; BALESTRIERI G
      DEFINITION OF ANTI RO RELATED RISK IN PREGNANCY

      Arthritis and rheumatism
    34. FAGLIA E; FAVALES F; QUARANTIELLO A; NOSARI I; CORTINOVIS F; GIRELLI A; ROCCA L; MORATTI F; BRAGA A; MARIANI G; PREVIATO M; TESTORI G; VILLANI P; ROCCA A; MUSACCHIO N; PALEARI F; GHEZZI A
      EFFECT OF AMLODIPINE ON INSULIN-SECRETION, GLUCOSE, LIPID PROFILE ANDURINARY ALBUMIN EXCRETION IN PATIENTS WITH MILD HYPERTENSION AND NON-INSULIN-DEPENDENT DIABETES

      Clinical drug investigation
    35. DUFFAUD F; ORSIERE T; VILLANI P; PELISSIER AL; VOLOT F; FAVRE R; BOTTA A
      COMPARISON BETWEEN MICRONUCLEATED LYMPHOCYTE RATES OBSERVED IN HEALTHY-SUBJECTS AND CANCER-PATIENTS

      Mutagenesis
    36. PELISSIER AL; LEONETTI G; VILLANI P; CIANFARANI F; BOTTA A
      CANNABIS - REVIEW OF TOXICOKINETICS AND B IOMONITORING METHODOLOGY

      Therapie
    37. FAGLIA E; FAVALES F; MORABITO A; RADICE M; SEGALINI G; MUSACCHIO N; ROCCA A; TORCHIO G; BOCCHIA M; MASTROPASQUA A; ROTABALDINI M; MORATTI F; BRAGA A; CUCCO C; GRASSINI R; BRIVIO M; CALIA P; DABALA A; TESTORI G; VILLANI P; NEGRINI M; RAMPINI P; MARIANI G; PREVIATO M; SAVIOTTI M; CALASTRA C; PALEARI F; GAMBA PL; CADEL A
      PREVALENCE OF UNRECOGNIZED SILENT-MYOCARDIAL-ISCHEMIA AND ITS ASSOCIATION WITH ATHEROSCLEROTIC RISK-FACTORS IN NONINSULIN-DEPENDENT DIABETES-MELLITUS

      The American journal of cardiology
    38. VILLANI P
      FRENCH DIPLOMATS AND AGENTS IN ITALY DURI NG THE FRENCH-REVOLUTION - CACAULT,FRANCOIS ACCOUNT OF EVENTS IN DECEMBER-1792

      Quaderni storici
    39. VILLANI P; ORSIERE T; DUFFAUD F; BOTTA A
      CYTOTOXIC AND GENOTOXIC EFFECTS OF 2,2'-AZOBIS (2-AMIDINOPROPANE) HYDROCHLORIDE (AAPH) IN CULTURED HUMAN T-LYMPHOCYTES

      Medical science research
    40. VILLANI P; MASERATI R; REGAZZI MB; GIACCHINO R; LORI F
      PHARMACOKINETICS OF HYDROXYUREA IN PATIENTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-I

      Journal of clinical pharmacology
    41. IACONA I; REGAZZI MB; SPADA M; VILLANI P; MOLINARO M; ALESSIANI M
      PHARMACOKINETIC PROFILE OF MYCOPHENOLIC-ACID IN PIGLETS AFTER SMELL BOWEL TRANSPLANTATION

      Transplantation proceedings
    42. REGAZZI MB; IACONA I; ALESSIANI M; SPADA M; VACCARISI S; VILLANI P; MOLINARO M
      INTERACTION BETWEEN FK-506 AND DILTIAZEM IN AN ANIMAL

      Transplantation proceedings
    43. VENEZIANO D; VILLANI P
      IDENTIFICATION OF RAIN CELLS FROM RADAR AND STOCHASTIC MODELING OF SPACE-TIME RAINFALL

      Meccanica
    44. VILLANI P
      DIGS GIUFFRE,JIMMY

      Down beat
    45. VILLANI P; REGAZZI MB; MASERATI R; VIALE P; ALBERICI F; GIACCHINO R
      CLINICAL AND PHARMACOKINETIC EVALUATION OF A NEW LIPID-BASED DELIVERYSYSTEM OF AMPHOTERICIN-B IN AIDS PATIENTS

      Arzneimittel-Forschung
    46. VILLANI P; OLIVERO S; BOTTA A
      CYTOKINESIS-BLOCK MICRONUCLEUS ASSAY IN CULTURED HUMAN T-LYMPHOCYTES - EVALUATION OF A THRESHOLD VALUE FOR SPONTANEOUS MICRONUCLEI

      Medical science research
    47. OLIVERO S; VILLANI P; BOTTA A
      GENOTOXIC EFFECTS OF COBALT CHLORIDE, SULFATE AND NITRATE ON CULTUREDHUMAN-LYMPHOCYTES

      Medical science research
    48. VILLANI P
      FRENCH AGENTS AND DIPLOMATS IN ITALY DURI NG THE FRENCH-REVOLUTION - EYMAR,ANGE,MARIE AND HIS MISSION TO GENOA (1793)

      Studi storici
    49. IACONA I; REGAZZI MB; BUGGIA I; VILLANI P; FIORITO V; MOLINARO M; GUARNONE E
      HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY DETERMINATION OF PRAVASTATIN IN PLASMA

      Therapeutic drug monitoring
    50. NETTI C; SIBILIA V; GUIDOBONO F; VILLANI P; PECILE A; BRAGA PC
      EVIDENCE FOR AN INHIBITORY ROLE OF CENTRAL HISTAMINE ON CARRAGEENAN-INDUCED HYPERALGESIA

      Neuropharmacology
    51. CATENA C; CONTI D; VILLANI P; NASTASI R; ARCHILEI R; RIGHI E
      MICRONUCLEI AND 3AB INDEX IN HUMAN AND CANINE LYMPHOCYTES AFTER IN-VITRO X-IRRADIATION

      MUTATION RESEARCH
    52. CATENA C; VILLANI P; CONTI D; RIGHI E
      MICRONUCLEI AND 3AB INDEX IN X-IRRADIATED HUMAN-LYMPHOCYTES IN G0 ANDG1 PHASES

      Mutation research
    53. Gennari, D.; Sena, Giuseppe; Vestrucci, Paolo; Villani, M.P.
      Energia ed innovazione, i risultati di un primo tentativo di analisi condotta a livello regionale

      Economia delle fonti di energia e dell'ambiente


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 06/06/20 alle ore 07:56:12